Stocktoria
Aprea Therapeutics, Inc. APRE
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2019-10-03
Aprea Therapeutics, Inc. financials (annual)
Bars are annual figures from 2018 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| R&D expense | — | — | — | — | $23.9M | $37.9M | $21.0M | $14.2M |
| Operating income | -$13.2M | -$14.3M | -$15.5M | -$113.4M | -$37.4M | — | — | — |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$12.6M | -$13.0M | -$14.3M | -$112.7M | -$37.1M | -$53.5M | -$28.1M | -$15.5M |
| EPS (diluted) | $-1.93 | $-2.35 | $-3.95 | $-67.99 | $-34.88 | $-50.61 | $-4.67 | — |
| Operating cash flow | -$12.9M | -$13.6M | -$12.2M | -$25.0M | -$37.7M | -$41.8M | -$26.7M | -$15.3M |
| Free cash flow | — | -$13.6M | -$12.3M | — | — | -$41.8M | -$26.7M | -$15.3M |
| Cash & equivalents | $14.6M | $22.8M | $21.6M | $28.8M | $53.1M | $89.0M | $130.1M | $65.7M |
| Total assets | $15.9M | $24.0M | $22.7M | $30.2M | $56.8M | $92.8M | $133.6M | $66.0M |
| Total liabilities | — | — | — | $3.2M | $7.3M | $15.4M | $9.4M | $4.9M |
| Shareholders' equity | $12.4M | $19.3M | $17.0M | $25.6M | $49.5M | $77.4M | $124.2M | -$51.4M |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.